Phara-Ambroise M, Cupul-Flores JL, Un-Hernández E, Velázquez-Morelos JA, Urzúa-Rodríguez NA

Language: Spanish
References: 13
Page: 42-44
PDF size: 283.67 Kb.

ABSTRACT

Introduction. Chronic obstructive pulmonary disease (COPD) is currently considered a public health problem and is the leading cause of chronic morbidity in the world. COPD is defined as a preventable and treatable pathology, partially reversible with the use of bronchodilators, characterized by a persistent airflow limitation, generally progressive and associated with an exaggerated inflammatory response of the airways and pulmonary parenchyma against gas particles harmful, especially, tobacco smoke.
Clinical case. We present the case of a 88-year-old male patient with a history of smoking, diagnosed with COPD for 5 years who presented to the emergency department with dysphonia, cough with whitish expectoration, odynophagia and dyspnea. medium efforts so it was decided intrahospital admission. He continued with audible laryngeal stridor, therefore he underwent a nasofibroscopy which reported probable glotho-subglotonic laryngeal cáncer.
Conclusion. The most important risk factor for the development of COPD is tobacco smoke, this is very related to laryngeal cancer because the consumption of tobacco and alcohol are considered the main risk factors for its development. Within the clinical manifestations of laryngeal cancer is mainly the persistence of dysphonia in glottic carcinoma, the symptoms that appear later include dysphagia, chronic cough, laryngeal stridor.

REFERENCES

1. Torres-Castro R, Céspedes C, Vilaró J, Vera-Uribe R, Cano-Cappellacci M, Vargas D. Evaluación de la actividad física en pacientes con enfermedad pulmonar obstructiva crónica. 2017; 145: 1588-1596.

2. Müllerova H, Maselli D, Locantore N, Vestbo J. Hurst J, Wedzicha J et al. Hospitalized Exacerbations of COPD Risk Factors and Outcomes in the ECLIPSE Cohort. Chest. 2015; 147(4): 999-1007.

3. Neumología y Cirugía de Tórax. Panorama epidemiológico e impacto económico actual; 66(S2):S13-S16, 2007.

4. Luna-Ortiz K, Villavicencio-Valencia V, Saucedo-Ramírez OJ, Rascón-Ortiz M. Cáncer de laringe en pacientes menores de 40 años. Cir Ciruj 2006;74:225- 229.

5. Legaza E S, Cauqui R S, Gallegos R G. Adenocarcinoma laríngeo no especificado a nivel glótico en un paciente fumador y bebedor. Salud(i) Ciencia 22 (2017) 447-449.

6. (GOLD) GIfCOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD. 2017.

7. Wedzicha JA, Singh R, Mackay AJ. Acute COPD Exacerbations. Clinics in chest medicnes. 2014; 35(1): p. 157-163.

8. Varela Arias MA, Bembibre Vázquez L, Marcos Rodríguez PJ. EPOC reagudizado en Urgencias Extrahospitalarias. Cadernos de atención primaria. 2013; 19: p. 144-146.

9. Ko FW, Chan KP, Hui DS, Goddard JR, Shaw JG, Reid DW, et al. Acute exacerbation of COPD. Respirology. 2016; 21(7): p. 1152-1165.

10. López-Giraldo A, Rodríguez-Roisin R, Agustí A. Enfermedad pulmonar obstructiva crónica. Actualización 2014. Medicina Balear. 2014; 29(1): p. 43-48.

11. Hernández García O, Castillo Romero E, Rodríguez Gómez I, Albert Rodríguez A, Fernández Barrera R. Factores de riesgo del cáncer laríngeo. Rev Ciencias Médicas. 2014; 18(6): p. 983-996.

12. Mata F, Agudo E, Canela C, García Colina J, Manzo A, Rodríguez A, et al. Concenso Nacional sobre cáncer de laringe diagnóstico y tratamiento. Revista Venezolana de Oncología. 2012; 24(1): p. 64-95.

13. Vineis P, Airoldi L, Veglia P, Olgiati L, Pastorelli R, Autrup H, et al. Environmental tobacco smoke and risk of respiratoy cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ. 2005; 330(7486): p. 277.